Drawing for DAKO TRUE POSITIVE ID

USPTO serial 79052635

DAKO TRUE POSITIVE ID

Reviewed by CopyMark Law Group

Reg. 3612641Status 707Registered
Filing date
Status date
Registration date
Apr 28, 2009
Examiner
PILARO, MARK F
Law office
—

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with DAKO TRUE POSITIVE ID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew Roppel

Andrew Roppel Holland & Hart LLPP.O. Box 8749Denver, CO 80201-8749UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Chemicals for use in industry and science; Chemical products and preparations used in industry and science, namely, reagents and diagnostic preparations for use in clinical and research use, diagnostic reagents for medical research use, diagnostic preparations and reagents for clinical or medical laboratory use and scientific or research use ]SECTION 71 - CANCELLED—
005[ Pharmaceutical and veterinary preparations for the treatment of infectious diseases, cancer and other immunodeficiency diseases, chemical reagents and diagnostic preparations for medical and veterinary use for the treatment of infectious diseases, cancer and other immunodeficiency diseases ]SECTION 71 - CANCELLED—
009[ Diagnostic apparatus and instruments, not for medical purposes, namely, apparatus for staining and/or visualization of tissue or cell based samples for diagnostic or scientific use; apparatus for detection of tissue and/or cell based samples and scientific apparatus for high speed cell and/or bead sorting and analysis; ] recorded and downloadable software used to identify and/or diagnose cancer and other immunodeficiency diseases, recorded and downloadable bioinformatics-enabled diagnostic software used to identify and/or diagnose cancer and other immunodeficiency diseases [ ; analysis apparatus for laboratory use for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining apparatus, high speed cell and/or bead sorting apparatus and bioinformatics-enabled diagnostic software data; measuring apparatus used to identify and/or diagnose cancer and other immunodeficiency diseases, not for medical use ]ACTIVE—
010[ Diagnostic apparatus and instruments for medical use, namely, apparatus for staining of tissue or cell based samples for diagnostic or medical use, apparatus for detection of tissue or cell based samples and apparatus for high-speed cell and/or bead sorting and analysis, all for medical purposes; medical analysis and medical measuring apparatus for staining of tissue or cell based samples for diagnostic or medical use, and analyzing results from apparatus for detection of tissue or cell based samples and apparatus for high-speed cell and/or bead sorting and analysis, all for medical purposes ]SECTION 71 - CANCELLED—
037[ Installation and integration of medical instruments, including with existing hospital and laboratory infrastructure; maintenance and servicing in connection with updating and upgrading of medical instruments; all for use in connection with medical analysis, diagnosis and research ]SECTION 71 - CANCELLED—
041[ Education, namely, workshops, web-based learning modules, courses and seminars, and training in the fields of medical analysis, diagnosis and research and clinical analysis, diagnosis and research; training in the use of scientific and medical instruments and software ]SECTION 71 - CANCELLED—
042Medical research; installation and integration of software, including with existing hospital and laboratory infrastructure; maintenance, servicing, updating and upgrading of software; all for use in connection with medical analysis, diagnosis and researchACTIVE—
044[ Medical services; health care; veterinary services, including medical analysis and diagnosis ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 25, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 23, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 23, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 29, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 6, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 25, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 25, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 25, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 25, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 9, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jun 10, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 10, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 10, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 10, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 6, 2020INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jan 30, 2020INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 30, 2020INPCINVALIDATION PROCESSED—
Jan 1, 2020INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 5, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 1, 2019NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 1, 201971.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Apr 17, 2019ES71TEAS SECTION 71 RECEIVED—
Apr 28, 2018REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Mar 1, 2018RNWLINTERNATIONAL REGISTRATION RENEWED—
May 19, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 7, 2015NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 7, 201571AGREGISTERED-SEC.71 ACCEPTED—
May 7, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 21, 2015ES71TEAS SECTION 71 RECEIVED—
Jan 13, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 11, 2011NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 10, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 10, 2009FIMPFINAL DISPOSITION PROCESSED—
Jul 28, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 28, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 10, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 21, 2009NPUBNOTICE OF PUBLICATION—
Jan 7, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 6, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Jan 5, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 5, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 5, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 18, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 16, 2008ALIEASSIGNED TO LIE—
Dec 5, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 2, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 2, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 20, 2008RFNTREFUSAL PROCESSED BY IB—
Jun 2, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 2, 2008RFRRREFUSAL PROCESSED BY MPU—
May 31, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 30, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2008DOCKASSIGNED TO EXAMINER—
May 23, 2008NWAPNEW APPLICATION ENTERED—
May 22, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance